Literature DB >> 8138771

HIV surveillance by testing saliva from injecting drug users: a national study in New Zealand.

N P Dickson1, F J Austin, C Paul, K J Sharples, D C Skegg.   

Abstract

OBJECTIVE: To determine whether the prevalence of HIV infection among injecting drug users in New Zealand has remained low since the introduction of a needle and syringe exchange scheme in May 1988.
DESIGN: Anonymous survey of intravenous drug users attending outlets of the exchange scheme, based on questionnaires and saliva testing.
SETTING: Twelve pharmacies and community outreach organisation in six cities.
SUBJECTS: Altogether 620 people provided saliva specimens and completed questionnaires. These represented 73% of those who visited exchange scheme outlets during a three month period in 1992. MAIN OUTCOME MEASURE: Saliva was tested for antibodies to HIV-1 and HIV-2 using an IgG-capture enzyme linked immunosorbent assay (GACELISA).
RESULTS: Of 591 specimens eligible for inclusion, only three (0.5%) were repeatedly reactive in the GACELISA test, while two of these were also positive in a Western blot test.
CONCLUSIONS: Although surveys show that sharing of needles and syringes was common in New Zealand until recently, the prevalence of HIV infection in intravenous drug users has remained low. This can probably be attributed to the success of educational campaigns and legislative action to allow a needle and syringe exchange scheme to be set up.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8138771      PMCID: PMC1059895          DOI: 10.1136/jech.48.1.55

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  9 in total

1.  International epidemiology of HIV and AIDS among injecting drug users.

Authors:  D C Des Jarlais; S R Friedman; K Choopanya; S Vanichseni; T P Ward
Journal:  AIDS       Date:  1992-10       Impact factor: 4.177

2.  HIV seropositivity in community-recruited and drug treatment samples of injecting drug users.

Authors:  T M Lampinen; E Joo; S Seweryn; R C Hershow; W Wiebel
Journal:  AIDS       Date:  1992-01       Impact factor: 4.177

3.  Evaluation of needle exchange in central London: behaviour change and anti-HIV status over one year.

Authors:  G J Hart; A L Carvell; N Woodward; A M Johnson; P Williams; J V Parry
Journal:  AIDS       Date:  1989-05       Impact factor: 4.177

4.  Comparison of saliva and blood for human immunodeficiency virus prevalence testing.

Authors:  C J Major; S E Read; R A Coates; A Francis; B J McLaughlin; M Millson; F Shepherd; M Fanning; L Calzavara; D MacFadden
Journal:  J Infect Dis       Date:  1991-04       Impact factor: 5.226

5.  Occurrence of AIDS in New Zealand: the first seven years. MRC AIDS Epidemiology Group.

Authors:  R V Carlson; D C Skegg; C Paul; G F Spears
Journal:  N Z Med J       Date:  1991-04-10

6.  Sensitive assays for viral antibodies in saliva: an alternative to tests on serum.

Authors:  J V Parry; K R Perry; P P Mortimer
Journal:  Lancet       Date:  1987-07-11       Impact factor: 79.321

7.  Unlinked anonymous monitoring of HIV prevalence at sexually transmitted disease clinics.

Authors:  N P Dickson; C Paul; D C Skegg; K J Sharples; P H Lyttle; P J Say; M C Croxson; D G Woodfield
Journal:  N Z Med J       Date:  1993-08-11

8.  Testing of saliva for antibodies to HIV-1.

Authors:  N Crofts; S Nicholson; P Coghlan; I D Gust
Journal:  AIDS       Date:  1991-05       Impact factor: 4.177

9.  AIDS--risk behaviours and AIDS knowledge in intravenous drug users.

Authors:  G M Robinson; N J Thornton; J Rout; N Mackenzie
Journal:  N Z Med J       Date:  1987-04-08
  9 in total
  1 in total

1.  Needle exchange programs: New Zealand's experience.

Authors:  B Lichtenstein
Journal:  Am J Public Health       Date:  1996-09       Impact factor: 9.308

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.